Pharmafile Logo

Say Goodbye to Costly Delays – Origins’ Clinical Trial Participant Simulations Have the Answer!

Lack of Patient Involvement in Clinical Trial Designs Causes Major Issues
Low recruitment and retention of clinical trials is a key issue faced by many clinical trials. These can lead to protocol adjustments resulting in increasing costs, as well as delays to successfully bringing a product to market; to patients who need it.

The Power of Clinical Trial Participant Simulations
Clinical trial simulation involves testing specific key aspects of the recruitment and conduct of a clinical trial with patients in a risk-free environment. It provides the opportunity to identify potential barriers to participation and to optimise the design, prior to trial initiation; therefore, creating a more positive experience for patients. A range of areas can be explored in a clinical trial simulation, including:

- PMLiVE

- PMLiVE

Solutions
Avoid costly delays with Origins’ clinical trial participant simulation. Reach out at contact@origins-patients.com to request more information or book a meeting with us by clicking here.

This content was provided by Origins – The Patient Focused Specialists

Company Details

 Latest Content from  Origins – The Patient Focused Specialists 

Using ethnography to uncover the authentic patient experience

Ahead of their webinar on 7th June ‘Revealing the true patient experience through ethnography’, Su Smith, Director of Origins Insights, looks at the benefits of ethnography from a patient and...

Were patients at the heart of your New Year’s Resolutions?

Over recent years, many pharma companies have increasingly stated that they have patients at the heart of their success objectives... but if they were to look back and decide whether...

Understanding the authentic patient experience can redefine the success of your clinical trial before you design it

. Su contributes our experience are Origins that there is a willingness within the Pharmaceutical Industry to change attitudes towards clinical trial populations – making them less about academic and...

RESONANT GROUP APPOINTS STEPHEN MARCHANT CHIEF DEVELOPMENT OFFICER

Stephen Marchant has joined Resonant Group in the newly created role of Chief Development Officer.  He will be working with the Board to create, grow and acquire businesses and services to...

Origins Insights nominated for two EVCOM Clarion Awards

Origins Insights excited to have our 'What One Thing...?' RDD film shortlisted for two awards!

Origins Insights wins the “Best Patient-Centric Approach” award at the BHBIA BOBI Awards 2021

Origins Insights thrilled to be named as winners at the BHBIA BOBI Awards 2021

Why we need to look at rare diseases in a different way

28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.